• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS RUBELLA IGG - IGG ANTIBODIES TO RUBELLA VIRUS; ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS RUBELLA IGG - IGG ANTIBODIES TO RUBELLA VIRUS; ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA Back to Search Results
Catalog Number 04618793190
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/10/2017
Event Type  malfunction  
Manufacturer Narrative
(b)(6).(b)(4).
 
Event Description
The customer complained of a false positive result for 1 pregnant patient tested for elecsys rubella igg immunoassay (rubella igg) on a cobas 6000 e 601 module.It is unclear if the positive result was reported outside of the laboratory.On (b)(6) 2017 the patient had a rubella igg result on the e601 module of 24.30 iu/ml (positive).On (b)(6) 2017 the patient had a rubella igg result on the e 601 module of 24.29 iu/ml (positive).The sample from (b)(6) 2017 was tested by the siemens method and the result was 4.43 iu/l (negative).The sample from (b)(6) 2017 was also tested by recomblot mikrogen and the conclusion was "traces" with a conclusion of uncertain presence of antibody.The patient is considered non-immune.There was no allegation that an adverse event occurred.The e601 module serial number was not provided.Samples from the patient were submitted for investigation.The customer¿s results from the sample from (b)(6) 2017 and the sample from (b)(6) 2017 were reproduced with results of 25.66 iu/ml (positive) and 22.86 iu/ml (positive) respectively.Investigations are ongoing.
 
Manufacturer Narrative
The customer's calibration and qc results were acceptable.Samples from the patient were investigated further.The sample from (b)(6) 2017 was tested by the platelia rubella igg method and the result was 2.18 iu/ml (negative).The sample was tested by recomblot rubella igg and the result was indeterminate.The sample was also tested with an in-house neutralization assay for rubella igg and the sample was neutralizable and therefore positive.During the preliminary investigation, the customer's results were confirmed as positive.During further investigation of the sample, differing results were received resulting in an overall outcome of indeterminate.The platelia rubella igg was found to be negative, although clearly above background (negative samples usually have values < 1.0 iu/ml).The recomblot method showed indeterminate reactivity.The neutralization assay result strongly indicates the presence of specific anti-rubella igg antibodies.This is supported by the customer's results.A specific root cause was not identified.Based on the information available, the assay performs within specification.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RUBELLA IGG - IGG ANTIBODIES TO RUBELLA VIRUS
Type of Device
ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key7078563
MDR Text Key94847390
Report Number1823260-2017-02812
Device Sequence Number1
Product Code LFX
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K072617
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 02/06/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number04618793190
Device Lot Number206194
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/16/2017
Initial Date FDA Received12/04/2017
Supplement Dates Manufacturer Received11/16/2017
Supplement Dates FDA Received02/06/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age26 YR
-
-